학술논문
Letter: Early real‐world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease—Authors' reply.
Document Type
Article
Source
Subject
*CROHN'S disease
Language
ISSN
0269-2813
Abstract
LINKED CONTENT: This article is linked to Yiu et al papers. To view these articles, visit https://doi.org/10.1111/apt.18006 and https://doi.org/10.1111/apt.18049 [ABSTRACT FROM AUTHOR]